These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 18680765

  • 21. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
    Geng Y, Monajembashi S, Shao A, Cui D, He W, Chen Z, Hemmerich P, Tang J.
    J Biol Chem; 2012 Aug 31; 287(36):30729-42. PubMed ID: 22773875
    [Abstract] [Full Text] [Related]

  • 22. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O, Provazníková D, Peslová G.
    Cas Lek Cesk; 2005 Aug 31; 144(2):90-4. PubMed ID: 15807293
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Regulation of p53 activity in nuclear bodies by a specific PML isoform.
    Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, Pandolfi PP, Will H, Schneider C, Del Sal G.
    EMBO J; 2000 Nov 15; 19(22):6185-95. PubMed ID: 11080164
    [Abstract] [Full Text] [Related]

  • 25. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.
    Jiang M, Entezami P, Gamez M, Stamminger T, Imperiale MJ.
    mBio; 2011 Nov 15; 2(1):e00281-10. PubMed ID: 21304169
    [Abstract] [Full Text] [Related]

  • 26. Regulation of apoptosis by PML and the PML-NBs.
    Bernardi R, Papa A, Pandolfi PP.
    Oncogene; 2008 Oct 20; 27(48):6299-312. PubMed ID: 18931695
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
    Komura N, Asakawa M, Umezawa K, Segawa K.
    Exp Cell Res; 2007 Aug 01; 313(13):2753-65. PubMed ID: 17585903
    [Abstract] [Full Text] [Related]

  • 29. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH, Liu CC, Yen CC, Gau JP, Wang WS, Tzeng CH.
    Int J Cancer; 2009 Jul 01; 125(1):71-7. PubMed ID: 19291793
    [Abstract] [Full Text] [Related]

  • 30. The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.
    Sarkari F, Wang X, Nguyen T, Frappier L.
    PLoS One; 2011 Jan 31; 6(1):e16598. PubMed ID: 21305000
    [Abstract] [Full Text] [Related]

  • 31. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
    Condemine W, Takahashi Y, Le Bras M, de Thé H.
    J Cell Sci; 2007 Sep 15; 120(Pt 18):3219-27. PubMed ID: 17878236
    [Abstract] [Full Text] [Related]

  • 32. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
    Doucas V, Tini M, Egan DA, Evans RM.
    Proc Natl Acad Sci U S A; 1999 Mar 16; 96(6):2627-32. PubMed ID: 10077561
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Patient mutations alter ATRX targeting to PML nuclear bodies.
    Bérubé NG, Healy J, Medina CF, Wu S, Hodgson T, Jagla M, Picketts DJ.
    Eur J Hum Genet; 2008 Feb 16; 16(2):192-201. PubMed ID: 17957225
    [Abstract] [Full Text] [Related]

  • 35. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.
    Hofmann TG, Möller A, Sirma H, Zentgraf H, Taya Y, Dröge W, Will H, Schmitz ML.
    Nat Cell Biol; 2002 Jan 16; 4(1):1-10. PubMed ID: 11740489
    [Abstract] [Full Text] [Related]

  • 36. PML bodies: a meeting place for genomic loci?
    Ching RW, Dellaire G, Eskiw CH, Bazett-Jones DP.
    J Cell Sci; 2005 Mar 01; 118(Pt 5):847-54. PubMed ID: 15731002
    [Abstract] [Full Text] [Related]

  • 37. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
    Ivanschitz L, Takahashi Y, Jollivet F, Ayrault O, Le Bras M, de Thé H.
    Proc Natl Acad Sci U S A; 2015 Nov 17; 112(46):14278-83. PubMed ID: 26578773
    [Abstract] [Full Text] [Related]

  • 38. A cytoplasmic PML mutant inhibits p53 function.
    Bellodi C, Kindle K, Bernassola F, Cossarizza A, Dinsdale D, Melino G, Heery D, Salomoni P.
    Cell Cycle; 2006 Nov 17; 5(22):2688-92. PubMed ID: 17172828
    [Abstract] [Full Text] [Related]

  • 39. p53 and p21(Waf1) are recruited to distinct PML-containing nuclear foci in irradiated and Nutlin-3a-treated U2OS cells.
    Shen H, Maki CG.
    J Cell Biochem; 2010 Dec 01; 111(5):1280-90. PubMed ID: 20803550
    [Abstract] [Full Text] [Related]

  • 40. Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies.
    Sides MD, Block GJ, Chadwick RW, Shan B, Flemington EK, Lasky JA.
    Virol J; 2011 Oct 05; 8():461. PubMed ID: 21975125
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.